Secretion and function of Cln5 during the early stages of Dictyostelium development

Area of Science:

• Cell Biology
• Neurodegenerative Diseases
• Biochemistry

Background:

• Mutations in CLN5 cause neuronal ceroid lipofuscinosis (NCL), a neurodegenerative disorder also known as Batten disease.
• A homolog of CLN5 was previously identified in Dictyostelium discoideum, a lower eukaryotic model system.
• Previous work showed Cln5-GFP fusion protein is secreted and functions as a glycoside hydrolase, identifying the molecular function of human CLN5.

Purpose of the Study:

• To investigate the secretion mechanism and function of the CLN5 protein in Dictyostelium.
• To explore the role of CLN5 in early development and its relationship with other NCL proteins.
• To gain insights into the molecular mechanisms underlying CLN5 function in human neurodegenerative diseases.

Main Methods:

• Generation of an antibody against Cln5 to detect endogenous protein secretion.
• Utilizing Cln5-GFP fusion protein to study secretion and localization.
• Analysis of cln5-deficient cells for developmental defects, protein interactions, and autofluorescence.

Main Results:

• Endogenous Cln5 is secreted during early Dictyostelium development via an unconventional, autophagy-linked pathway, bypassing the Golgi.
• Cln5 undergoes glycosylation, a post-translational modification essential for its secretion.
• Loss of Cln5 function in Dictyostelium leads to defects in adhesion and chemotaxis, and observed autofluorescence, mirroring findings in mammalian systems.

Conclusions:

• CLN5 plays a role in early multicellular development, with its secretion mechanism offering novel insights.
• The study provides evidence for molecular networking among NCL proteins, suggesting coordinated functions.
• Findings contribute to understanding CLN5 function in humans and may inform therapeutic strategies for Batten disease.